Who owns Cryo-Cell International, Inc.?
Institutional ownership of CCEL from SEC Form 13F filings across 12 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
12
13F holders
$1.8M
value, 2026 filers
6.9%
of shares outstanding (555,125 sh)
2
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30· % of fund = share of the manager's own book · % of co. = share of CCEL's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | SFI Advisors, LLC | 165,300 | $527,307 | 0.5% | 2.1% | 0.0% |
| 2 | VANGUARD CAPITAL MANAGEMENT LLC | 164,976 | $526,273 | 0.0% | 2% | -48.9% |
| 3 | MassMutual Private Wealth & Trust, FSB | 111,035 | $354,202 | 0.0% | 1.4% | 0.0% |
| 4 | GEODE CAPITAL MANAGEMENT, LLC | 46,273 | $147,651 | 0.0% | 0.6% | +6.1% |
| 5 | VANGUARD FIDUCIARY TRUST CO | 23,346 | $74,474 | 0.0% | 0.3% | 0.0% |
| 6 | FMR LLCNEW | 20,000 | $63,800 | 0.0% | 0.2% | new |
| 7 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 14,064 | $44,864 | 0.0% | 0.2% | +40.4% |
| 8 | BlackRock, Inc. | 6,696 | $21,361 | 0.0% | 0.1% | -52.1% |
| 9 | OSAIC HOLDINGS, INC. | 2,500 | $7,975 | 0.0% | 0% | 0.0% |
| 10 | MORGAN STANLEY | 605 | $1,930 | 0.0% | 0% | +0.7% |
| 11 | UBS Group AG | 316 | $1,008 | 0.0% | 0% | -53.0% |
| 12 | BARCLAYS PLCNEW | 14 | $45 | 0.0% | 0% | new |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.